0
ARTICLE |

Methylene Blue for Eczema Herpeticum

Te-Wen Chang, MD
JAMA. 1975;233(9):987. doi:10.1001/jama.1975.03260090053028.
Text Size: A A A
Published online

Eczema herpeticum has emerged as the most common form of Kaposi varicelliform eruption since the discontinuation of routine smallpox vaccination. It can be a serious complication of infantile eczema, with a death rate as high as 9%.1 Successful treatment with systemic administration of cytarabine has been reported, but the true value of this drug remains to be determined.2 Furthermore, cytarabine is not without toxic effects—notably bone marrow depression— after being administered systemically.

Methylene blue, a phenothiazine derivative, has been shown to be viricidally active toward herpesvirus hominis in the presence of light exposure, both in vitro3 and in vivo.4 The dye enters living cells, but transiently, thus inactivating both extracellular and intracellular viruses with minimal damage to the cells. Recently, a controlled study indicated methylene blue's therapeutic effectiveness in eczema herpeticum.5 Local application of 0.1% methylene blue solution to half of the diseased area followed

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();